PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How common is surgery to treat inflammatory bowel disease?

ANSWER

Even though surgery will not cure Crohn's disease, approximately 50% of people with Crohn's require surgery at some point. If you have Crohn's disease and require surgery, your doctor will discuss your options with you. Be sure you ask questions and understand the goal or goals of the surgery, its risks and benefits, and what could happen if you don't have the surgery.

From: Inflammatory Bowel Disease WebMD Medical Reference

Reviewed by Minesh Khatri on September 16, 2019

Medically Reviewed on 9/16/2019

SOURCE:  National Digestive Diseases Information Clearinghouse, National Institutes of Health. FDA. “FDA approves Inflectra, a biosimilar to Remicade.” “FDA approves Amjevita, a biosimilar to Humira.” Crohn's & Colitis Foundation of America."Maintenance Therapy." "What is Crohn's Disease?" "What is Ulcerative Colitis?"  



Reviewed by Minesh Khatri on September 16, 2019

SOURCE:  National Digestive Diseases Information Clearinghouse, National Institutes of Health. FDA. “FDA approves Inflectra, a biosimilar to Remicade.” “FDA approves Amjevita, a biosimilar to Humira.” Crohn's & Colitis Foundation of America."Maintenance Therapy." "What is Crohn's Disease?" "What is Ulcerative Colitis?"  



Reviewed by Minesh Khatri on September 16, 2019

NEXT QUESTION:

What is the outlook for people with inflammatory bowel disease (IBD)?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.